AGM
ATYR icon

Alpine Global Management’s aTyr Pharma ATYR Stock Holding History

Alpine Global Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,429
Closed -$63.1K – 219
2024
Q4 		$63.1K Buy
+17,429
New +$52.8K 0.02% 143

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Alpine Global Management's ATYR Position: Q1 2025 in Review

Alpine Global Management sold out of aTyr Pharma (ATYR) in Q1 2025, closing a stake of 17,429 shares — an estimated $63.1K sold.

Alpine Global Management first reported a position in ATYR in Q4 2024 and held it in 1 quarter. The position peaked at $63.1K in Q4 2024. 87 funds tracked by Wall St. Rank hold ATYR as of Q1 2025.

  • Alpine Global Management reported no remaining aTyr Pharma position as of Q1 2025 after selling out during the quarter.
  • Alpine Global Management sold 17,429 aTyr Pharma shares in Q1 2025, an estimated $63.1K.
  • Alpine Global Management first reported a position in aTyr Pharma in Q4 2024 and held it in 1 quarter.
  • Alpine Global Management's aTyr Pharma position peaked at $63.1K in Q4 2024.
  • 87 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2025.

Based on Alpine Global Management's 13F filing for Q1 2025, filed 15 May 2025.